161 related articles for article (PubMed ID: 9169336)
1. Topical calcipotriene in combination with UVB phototherapy for psoriasis.
Hecker D; Lebwohl M
Int J Dermatol; 1997 Apr; 36(4):302-3. PubMed ID: 9169336
[TBL] [Abstract][Full Text] [Related]
2. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis.
Bruce S; Epinette WW; Funicella T; Ison A; Jones EL; Loss R; McPhee ME; Whitmore C
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):755-9. PubMed ID: 7929921
[TBL] [Abstract][Full Text] [Related]
6. Combination TL01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial.
Woo WK; McKenna KE
Br J Dermatol; 2003 Jul; 149(1):146-50. PubMed ID: 12890208
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study.
Ring J; Kowalzick L; Christophers E; Schill WB; Schöpf E; Ständer M; Wolff HH; Altmeyer P
Br J Dermatol; 2001 Mar; 144(3):495-9. PubMed ID: 11260005
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and UVB radiation therapy.
Kragballe K
Cutis; 2002 Nov; 70(5 Suppl):9-12. PubMed ID: 12467333
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
Koo J
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
[TBL] [Abstract][Full Text] [Related]
10. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis.
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033
[TBL] [Abstract][Full Text] [Related]
11. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group.
Molin L
Dermatology; 1999; 198(4):375-81. PubMed ID: 10490297
[TBL] [Abstract][Full Text] [Related]
12. Photosensitivity associated with combined UV-B and calcipotriene therapy.
McKenna KE; Stern RS
Arch Dermatol; 1995 Nov; 131(11):1305-7. PubMed ID: 7503575
[TBL] [Abstract][Full Text] [Related]
13. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
Bowman PH; Maloney JE; Koo JY
J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
15. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group.
Highton A; Quell J
J Am Acad Dermatol; 1995 Jan; 32(1):67-72. PubMed ID: 7822519
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
[TBL] [Abstract][Full Text] [Related]
17. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
18. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
Arch Dermatol; 2000 Dec; 136(12):1536-43. PubMed ID: 11115167
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment.
Rogers C
Dermatol Nurs; 2006 Jun; 18(3):258-61. PubMed ID: 16856679
[TBL] [Abstract][Full Text] [Related]
20. Combination phototherapy of psoriasis with calcipotriene and narrow-band (311 nm) UVB.
Lehmann P; Kerscher M
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):501-2. PubMed ID: 9091500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
